Edition:
United Kingdom

Qiagen NV (QIA.DE)

QIA.DE on Xetra

31.90EUR
21 Sep 2018
Change (% chg)

€-0.47 (-1.45%)
Prev Close
€32.37
Open
€32.50
Day's High
€32.63
Day's Low
€31.90
Volume
3,026,958
Avg. Vol
529,904
52-wk High
€34.05
52-wk Low
€25.22

Latest Key Developments (Source: Significant Developments)

Qiagen reports quarterly Net Sales Of $377.2 Million
Tuesday, 31 Jul 2018 

July 31 (Reuters) - Qiagen NV ::QTRLY NET SALES OF $377.2 MILLION (+8% ACTUAL, +6% AT CONSTANT EXCHANGE RATES, OR CER) VERSUS. 5-6% CER GUIDANCE.QTRLY EPS OF $0.16; ADJUSTED EPS $0.34.QTRLY OPERATING INCOME MARGIN OF 14% OF SALES; ADJUSTED OPERATING INCOME MARGIN RISES TO 27% OF NET SALES.NGS-RELATED SALES SET TO ACHIEVE 2018 TARGET FOR MORE THAN $140 MILLION.QIAGEN REAFFIRMS 2018 OUTLOOK FOR GROWTH IN NET SALES AND ADJUSTED EPS.  Full Article

HTG Molecular Diagnostics Inc Says On March 30, 2018, Co And Qiagen Manchester Limited Entered Second Amendment Of First Statement Of Work
Wednesday, 4 Apr 2018 

April 5 (Reuters) - HTG Molecular Diagnostics Inc :HTG MOLECULAR DIAGNOSTICS INC - ON MARCH 30, 2018, CO AND QIAGEN MANCHESTER LIMITED ENTERED SECOND AMENDMENT OF FIRST STATEMENT OF WORK - SEC FILING.HTG MOLECULAR DIAGNOSTICS INC - QIAGEN HAS AGREED TO PAY COMPANY LOW, SINGLE-DIGIT MILLIONS OF DOLLARS IN DEVELOPMENT FEES FOR NEXT-PHASE ACTIVITIES.HTG- QIAGEN ALSO AGREED TO PAY CO MILESTONE UPTO AMOUNT IN LOW,SINGLE-DIGIT MLN OF DOLLARS ON ACHIEVEMENT OF SOME MILESTONES IN NEXT-PHASE ACTIVITIES.HTG MOLECULAR DIAGNOSTICS INC - THE NEXT-PHASE ACTIVITIES ARE EXPECTED TO BE COMPLETED IN Q2 OF 2018.  Full Article

Qiagen Q4 Loss Per Share $0.18 Including Items
Wednesday, 31 Jan 2018 

Jan 31 (Reuters) - Qiagen Nv ::QIAGEN REPORTS RESULTS FOR FOURTH QUARTER AND FULL-YEAR 2017, ANNOUNCES STAT-DX ACQUISITION AND NEW $200 MILLION SHARE REPURCHASE.Q4 SALES ROSE 8 PERCENT TO $396.9 MILLION.Q4 LOSS PER SHARE $0.18 INCLUDING ITEMS.Q4 ADJUSTED EARNINGS PER SHARE $0.43.REAFFIRMS 2020 MID-TERM TARGETS.Q4 EARNINGS PER SHARE VIEW $0.40 -- THOMSON REUTERS I/B/E/S.FOR 2018, EXPECTS UNDERLYING GROWTH IN ADJUSTED EARNINGS PER SHARE TO BE APPROXIMATELY $1.38-$1.40 CER.FOR 2018, QIAGEN EXPECTS UNDERLYING GROWTH IN ADJUSTED EARNINGS PER SHARE EXPECTED TO BE REDUCED TO ABOUT $1.31-1.33 CER.ORGANIC GROWTH IN NET SALES IS EXPECTED TO BE ABOUT 6-7% CER FOR 2018.  Full Article

Qiagen Signs Agreement To Acquire Stat-Dx
Wednesday, 31 Jan 2018 

Jan 31 (Reuters) - Qiagen Nv ::QIAGEN ENTERS INTO AGREEMENT TO ACQUIRE STAT-DX, PLANS TO LAUNCH A NEXT-GENERATION, FULLY INTEGRATED MULTIPLEX PLATFORM FOR SYNDROMIC DISEASE TESTING.QIAGEN NV - NEW SYSTEM LAUNCH PLANNED FOR H2 2018 WITH TWO CE-IVD MOLECULAR DIAGNOSTICS, U.S. LAUNCH PLANNED FOR 2019.  Full Article

Facebook Reports Qtrly Earnings Per Share $1.44
Wednesday, 31 Jan 2018 

Jan 31 (Reuters) - Facebook Inc ::FACEBOOK REPORTS FOURTH QUARTER AND FULL YEAR 2017 RESULTS.QTRLY EARNINGS PER SHARE $1.44.QTRLY TOTAL REVENUE $12,972 MILLION VERSUS $8,809 MILLION.DAUS WERE 1.40 BILLION ON AVERAGE FOR DECEMBER 2017, AN INCREASE OF 14% YEAR-OVER-YEAR‍​.MAUS WERE 2.13 BILLION AS OF DECEMBER 31, 2017, AN INCREASE OF 14% YEAR-OVER-YEAR.QTRLY ADVERTISING REVENUE $12,779 MILLION VERSUS $8,629 MILLION.HEADCOUNT WAS 25,105 AS OF DECEMBER 31, 2017, AN INCREASE OF 47% YEAR-OVER-YEAR‍​.QTRLY OPERATING MARGIN 57 PERCENT VERSUS 52 PERCENT.FACEBOOK - MADE CHANGES IN QUARTER THAT REDUCED TIME SPENT ON FACEBOOK BY ROUGHLY 50 MILLION HOURS EVERY DAY.AS A RESULT OF TAX LAW, PROVISION FOR INCOME TAXES INCREASED BY $2.27 BILLION,DILUTED EPS DECREASED BY $0.77 FOR Q4, FULL YEAR 2017‍​.FACEBOOK - MOBILE ADVERTISING REVENUE REPRESENTED ABOUT 89% OF ADVERTISING REVENUE FOR Q4 2017, UP FROM ABOUT 84% OF ADVERTISING REVENUE IN Q4 2016.Q4 EARNINGS PER SHARE VIEW $1.95, REVENUE VIEW $12.55 BILLION -- THOMSON REUTERS I/B/E/S.  Full Article

Qiagen to exceed $140 mln of NGS-related sales In 2018
Monday, 8 Jan 2018 

Jan 8 (Reuters) - Qiagen Nv ::SAYS ‍GOAL SET TO EXCEED $140 MILLION OF NGS-RELATED SALES IN 2018, UP FROM OVER $115 MILLION IN 2017​.  Full Article

Qiagen, DiaSorin partner in automated tuberculosis detection
Monday, 8 Jan 2018 

Jan 8 (Reuters) - Qiagen Nv ::SAYS ‍QIAGEN AND DIASORIN PARTNER TO OFFER FULLY AUTOMATED TUBERCULOSIS DETECTION WITH QUANTIFERON-TB GOLD PLUS AVAILABLE ON LIAISON ANALYZER SYSTEMS​.SAYS ‍DIASORIN TO ADD NOVEL CONTENT TO ALREADY BROAD LIAISON MENU, OVER 7,000 SYSTEMS INSTALLED​.SAYS ‍ANNOUNCES MILESTONE OF OVER 40 MILLION QUANTIFERON-TB TESTS SINCE LAUNCH​.  Full Article

Diasorin And Qiagen Partner To Offer Fully Automated Solution For Diagnosis Of Tuberculosis
Monday, 8 Jan 2018 

Jan 8 (Reuters) - DIASORIN SPA ::ANNOUNCES PARTNERSHIP WITH QIAGEN TO OFFER FULLY AUTOMATED SOLUTION FOR DIAGNOSIS OF TUBERCULOSIS.UNDER AGREEMENT, PARTIES ARE DEVELOPING FULLY AUTOMATED VERSION OF QUANTIFERON TEST READ-OUT COMPONENTS.  Full Article

Qiagen To Take Impairment On Deferred Tax Assets
Friday, 22 Dec 2017 

Dec 22 (Reuters) - Qiagen NV ::QIAGEN TO TAKE IMPAIRMENT ON DEFERRED TAX ASSETS, INFORMS ON EXPECTED IMPACTS OF NEW U.S. TAX LAW AND OTHER CHANGES IN GLOBAL TAX ENVIRONMENT.QIAGEN - WILL TAKE AN AFTER-TAX CHARGE ON NET INCOME OF ABOUT $110 MILLION-$120 MILLION (OR ABOUT $0.47-$0.52 PER SHARE) IN Q4.QIAGEN NV - WILL TAKE ADDITIONAL AFTER-TAX CHARGE IN 2018 OF ABOUT $7 MILLION (OR ABOUT $0.03 PER SHARE).  Full Article

‍Qiagen says it ‍will Take Extraordinary After-Tax Charge On Net Income Of About $110-120 mln In Q4 2017 Due To US Tax Reform
Friday, 22 Dec 2017 

Dec 22 (Reuters) - Qiagen Nv ::‍QIAGEN TO TAKE IMPAIRMENT ON DEFERRED TAX ASSETS, INFORMS ON EXPECTED IMPACTS OF NEW U.S. TAX LAW AND OTHER CHANGES IN GLOBAL TAX ENVIRONMENT​.DUE TO US TAX REFORM ‍WILL TAKE EXTRAORDINARY AFTER-TAX CHARGE ON NET INCOME OF ABOUT $110-120 MILLION IN Q4 OF 2017​.WILL ALSO TAKE ‍AN ADDITIONAL EXTRAORDINARY AFTER-TAX CHARGE IN 2018 OF APPROXIMATELY $7 MILLION (OR ABOUT $0.03 PER SHARE)​.‍AS A RESULT, A NEW AFTER-TAX CHARGE OF APPROXIMATELY $10 MILLION IS PLANNED TO BE TAKEN IN Q4 OF 2017​.SAYS ‍DOES NOT EXPECT ANY ADDITIONAL MATERIAL NON-M&A RELATED RESTRUCTURING CHARGES IN 2018​.‍DO NOT AFFECT QIAGEN'S ADJUSTED EPS FORECAST FOR Q4 AND FULL-YEAR 2018.CURRENTLY EXPECTS A PRELIMINARY ADJUSTED TAX RATE FOR FULL-YEAR 2018 OF APPROXIMATELY 20-21%.‍EXTRAORDINARY COSTS WILL BE EXCLUDED FROM ADJUSTED RESULTS​.  Full Article

German stocks - Factors to watch on Sept. 24

FRANKFURT/BERLIN, Sept 24 The following are some of the factors that may move German stocks on Monday: